Moderate fish-oil supplementation reverses low-platelet, long-chain n-3 polyunsaturated fatty acid status and reduces plasma triacylglycerol concentrations in British Indo-Asians

Am J Clin Nutr. 2004 Jun;79(6):974-82. doi: 10.1093/ajcn/79.6.974.

Abstract

Background: The mechanisms involved in the increased mortality from coronary artery disease in British Indo-Asians are not well understood.

Objectives: This study aimed to investigate whether British Indo-Asian Sikhs have higher plasma triacylglycerol concentrations, lower platelet phospholipid levels, and lower dietary intakes of long-chain n-3 polyunsaturated fatty acids (PUFAs) than do age- and weight-matched Europeans and whether moderate dietary fish-oil intake can reverse these differences.

Design: A randomized, double-blind, placebo-controlled, parallel, fish-oil intervention study was performed. After a 2-wk run-in period, 44 Europeans and 40 Indo-Asian Sikhs were randomly assigned to receive either 4.0 g fish oil [1.5 g eicosapentaenoic acid (EPA) and 1.0 g docosahexaenoic acid (DHA)] or 4.0 g olive oil (control) daily for 12 wk.

Results: At baseline, the Indo-Asians had significantly higher plasma triacylglycerol, small dense LDL, apolipoprotein B, and dietary and platelet phospholipid n-6 PUFA values and significantly lower long-chain n-3 PUFAs (EPA and DHA) than did the Europeans. A significant decrease in plasma triacylglycerol, plasma apolipoprotein B-48, and platelet phospholipid arachidonic acid concentrations and a significant increase in plasma HDL concentrations and platelet phospholipid EPA and DHA levels were observed after fish-oil supplementation. No significant effect of ethnicity on the responses to fish-oil supplementation was observed.

Conclusions: Moderate fish-oil supplementation contributes to a reversal of lipid abnormalities and low n-3 PUFA levels in Indo-Asians and should be considered as an important, yet simple, dietary manipulation to reduce CAD risk in Indo-Asians with an atherogenic lipoprotein phenotype.

Publication types

  • Clinical Trial
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Coronary Disease / etiology
  • Coronary Disease / mortality
  • Dietary Fats / administration & dosage
  • Dietary Fats / pharmacology*
  • Dietary Supplements*
  • Double-Blind Method
  • Fatty Acids, Omega-3
  • Fatty Acids, Unsaturated / administration & dosage
  • Fatty Acids, Unsaturated / blood*
  • Female
  • Fish Oils / administration & dosage
  • Fish Oils / pharmacology*
  • Humans
  • India / ethnology
  • Male
  • Middle Aged
  • Phospholipids / blood*
  • Triglycerides / administration & dosage
  • Triglycerides / blood*
  • United Kingdom

Substances

  • Dietary Fats
  • Fatty Acids, Omega-3
  • Fatty Acids, Unsaturated
  • Fish Oils
  • Phospholipids
  • Triglycerides
  • Pikasol